-
1.发明授权SCHUTZ VON ZELLEN MIT BBI IM ZUSAMMENHANG MIT EINER BEHANDLUNG MIT CHEMISCHEN AGENZIEN 有权与BBI小区在化学制剂任何处理连接保护
公开(公告)号：EP1150705B1
公开(公告)日：2004-05-26
申请号：EP00907521.9
申请日：2000-02-08
摘要： The invention relates to the utilization of a peptide for the protection of cells in connection with an in vivo and/or in vitro treatment with chemical agents. Said peptide comprises a modified form and/or optionally a modified fragment of a Bowman-Birk protease inhibitor (BBI). The invention also relates to the utilization of nucleic acid for the protection of cell in connection with an in vivo and/or in vitro treatment with chemical agents, wherein the nucleic acid comprises a sequence segment coding for the at least one peptide mentioned above.
-
2.发明公开SCHUTZ VON ZELLEN IM ZUSAMMENHANG MIT EINER BEHANDLUNG MIT CHEMISCHEN AGENZIEN 有权与BBI小区在化学制剂任何处理连接保护
公开(公告)号：EP1150705A2
公开(公告)日：2001-11-07
申请号：EP00907521.9
申请日：2000-02-08
摘要： The invention relates to the utilization of a peptide for the protection of cells in connection with an in vivo and/or in vitro treatment with chemical agents. Said peptide comprises a modified form and/or optionally a modified fragment of a Bowman-Birk protease inhibitor (BBI). The invention also relates to the utilization of nucleic acid for the protection of cell in connection with an in vivo and/or in vitro treatment with chemical agents, wherein the nucleic acid comprises a sequence segment coding for the at least one peptide mentioned above.
-
搜索结果
2 条记录 (耗时 0.011 秒)
